|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Congenital Syphilis Screen, FTA (IgG, IgM)
Test Code34323
CPT Codes
86780 (x2)<br>This test is not available for New York patient testing
Preferred Specimen
1 mL serum
Minimum Volume
0.1 mL
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
Immunofluorescence Assay (IFA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Fri; Report available: 2-4 days
Reference Range
Treponema pallidum Ab (IgG) | Non-Reactive |
Treponema pallidum Ab (IgM) | Non-Reactive |
Clinical Significance
This panel detects both IgG and IgM Antibodies to T. pallidum, the causative agent of syphilis. Its intended use is to differentiate fetal from maternal antibody in cases of suspected congenital syphilis infection. A positive (reactive) result for FTA IgM in the infant is indicative of infection.